CN Patent

CN108542906A — 治疗增生性疾病的方法

Assigned to Novartis AG · Expires 2018-09-18 · 8y expired

What this patent protects

本发明涉及用丝氨酸/苏氨酸激酶抑制剂治疗患者的方法，其中通过间歇给药方案给予丝氨酸/苏氨酸激酶抑制剂来抑制对丝氨酸/苏氨酸激酶抑制剂治疗的抗性。

USPTO Abstract

本发明涉及用丝氨酸/苏氨酸激酶抑制剂治疗患者的方法，其中通过间歇给药方案给予丝氨酸/苏氨酸激酶抑制剂来抑制对丝氨酸/苏氨酸激酶抑制剂治疗的抗性。

Drugs covered by this patent

Patent Metadata

Patent number
CN108542906A
Jurisdiction
CN
Classification
—
Expires
2018-09-18
Drug substance claim
No
Drug product claim
No
Assignee
Novartis AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.